Financhill
Back

BioNTech SE 10K Form

Sell
44

BNTX
BioNTech SE

Last Price:
107.04
Seasonality Move:
3.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNTX News And Ratings

See the #1 stock for the next 7 days that we like better than BNTX

BNTX Financial Statistics

Sales & Book Value

Annual Sales: $4.13B
Cash Flow: $-770.16M
Price / Cash Flow: 23.85
Annual Sales: $89.05
Price / Book: 1.14

Profitability

EPS (TTM): -2.11460
Net Income (TTM): $-501.07M
Gross Margin: $3.49B
Return on Equity: -2.35%
Return on Assets: -2.06%

BioNTech SE Earnings Forecast

Key BioNTech SE Financial Ratios

  • The Gross Profit Margin over the past 7 years for BNTX is 84.29%.
  • The Selling, General & Administrative Expenses for BNTX have been equal to 14.60% of Gross Profit Margin.
  • The Research & Development expenses have been 46.69% of Revenue.
  • The Interest Expense is 0.17% of Operating Income.
  • The Net Earning history of BNTX is 24.36% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

BioNTech SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BNTX
CUSIP: 09075V
Website: biontech.de

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 7.33
Quick Ratio: 7.1

Price-to-Earnings

Trailing P/E Ratio: 24.57
Forward P/E Ratio: 0

BNTX Technical Analysis vs Fundamental Analysis

Sell
44
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy or a Sell?

  • BioNTech SE stock is rated a Sell
    The current BioNTech SE [BNTX] share price is $102.14. The Score for BNTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.